Amos CI - Search Results

1

A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma.

Nguyen TT, Lee HS, Burt BM, Wu J, Zhang J, Amos CI, Cheng C. Nguyen TT, et al. Among authors: amos ci. Genome Med. 2022 Jan 12;14(1):5. doi: 10.1186/s13073-021-01010-w. Genome Med. 2022. PMID: 35016696 Free PMC article.

2

RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.

Li Y, Xiao X, Ji X, Liu B, Amos CI. Li Y, et al. Among authors: amos ci. Tumour Biol. 2015 Nov;36(11):8993-9003. doi: 10.1007/s13277-015-3576-y. Epub 2015 Jun 17. Tumour Biol. 2015. PMID: 26081616 Free PMC article.

3

Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.

Cai G, Xiao F, Cheng C, Li Y, Amos CI, Whitfield ML. Cai G, et al. Among authors: amos ci. PLoS One. 2017 Apr 20;12(4):e0175850. doi: 10.1371/journal.pone.0175850. eCollection 2017. PLoS One. 2017. PMID: 28426704 Free PMC article.

4

A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.

Zhao Y, Varn FS, Cai G, Xiao F, Amos CI, Cheng C. Zhao Y, et al. Among authors: amos ci. Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):86-95. doi: 10.1158/1055-9965.EPI-17-0478. Epub 2017 Nov 15. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29141854 Free PMC article.

5

Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy.

Varn FS, Tafe LJ, Amos CI, Cheng C. Varn FS, et al. Among authors: amos ci. Oncoimmunology. 2018 Mar 15;7(6):e1431084. doi: 10.1080/2162402X.2018.1431084. eCollection 2018. Oncoimmunology. 2018. PMID: 29872556 Free PMC article.

6

A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.

Zhao Y, Schaafsma E, Gorlov IP, Hernando E, Thomas NE, Shen R, Turk MJ, Berwick M, Amos CI, Cheng C. Zhao Y, et al. Among authors: amos ci. Mol Cancer Res. 2019 Jan;17(1):109-119. doi: 10.1158/1541-7786.MCR-18-0173. Epub 2018 Aug 31. Mol Cancer Res. 2019. PMID: 30171176 Free PMC article.

7

Statins associate with improved mortality among patients with certain histological subtypes of lung cancer.

Ung MH, MacKenzie TA, Onega TL, Amos CI, Cheng C. Ung MH, et al. Among authors: amos ci. Lung Cancer. 2018 Dec;126:89-96. doi: 10.1016/j.lungcan.2018.10.022. Epub 2018 Oct 25. Lung Cancer. 2018. PMID: 30527197 Free PMC article.

8

Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma.

Kamal Y, Cheng C, Frost HR, Amos CI. Kamal Y, et al. Among authors: amos ci. Oncoimmunology. 2018 Oct 16;8(1):e1500106. doi: 10.1080/2162402X.2018.1500106. eCollection 2019. Oncoimmunology. 2018. PMID: 30546942 Free PMC article.

9

A gene expression-based immune signature for lung adenocarcinoma prognosis.

Wang L, Luo X, Cheng C, Amos CI, Cai G, Xiao F. Wang L, et al. Among authors: amos ci. Cancer Immunol Immunother. 2020 Sep;69(9):1881-1890. doi: 10.1007/s00262-020-02595-8. Epub 2020 May 5. Cancer Immunol Immunother. 2020. PMID: 32372138 Free PMC article.

10

Human genes differ by their UV sensitivity estimated through analysis of UV-induced silent mutations in melanoma.

Gorlov IP, Amos CI, Tsavachidis S, Begg C, Hernando E, Cheng C, Shen R, Orlow I, Luo L, Ernstoff MS, Parker J, Thomas NE, Gorlova OY, Berwick M. Gorlov IP, et al. Among authors: amos ci. Hum Mutat. 2020 Oct;41(10):1751-1760. doi: 10.1002/humu.24078. Epub 2020 Jul 15. Hum Mutat. 2020. PMID: 32643855 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

863 results

Search Page

Filters